The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol plus metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin

Cakiroglu Y., Vural B., Isgoren S.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.288, sa.1, ss.213-220, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 288 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00404-013-2742-y
  • Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.213-220
  • Anahtar Kelimeler: Polycystic ovary syndrome, Leptin, Ghrelin, Drospirenone-ethinyl estradiol, Metformin, POLYCYSTIC-OVARY, ULTRASOUND EXAMINATION, INSULIN-RESISTANCE, WOMEN, ENDOCRINE, OBESE, CONSENSUS, FEATURES, PCOS
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Polycystic ovary syndrome (PCOS) is considered as the most common endocrinopathy among women of reproductive age. Oral contraceptives (OCs) and metformin are one of the main drug groups in the long-term treatment of PCOS. This study was undertaken to investigate the effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ultrasonographic markers, body fat mass (BFM) index, leptin-ghrelin.